Muutke küpsiste eelistusi
  • Formaat - EPUB+DRM
  • Hind: 59,79 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Raamatukogudele

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

"This book provides a comprehensive examination of the pharmaceutical and medical device industry, including analysis of its current trade and innovation strategies. Opening with a survey of the global pharmaceutical and medical device industry, Bhardwajoutlines the growing trade and trade interdependence among countries in the global supply chain. He adopts a trade competitiveness approach to analyse patterns of product specialisation, and examines the drug discovery process and its challenges in translating bioscientific knowledge into lifesaving products. Bhardwaj argues that further economic integration, collaborative R&D and digital technologies may help accelerate productivity and address global challenges of escalating drug costs, neglected tropical diseases (NTDs) and pandemic risks. The book also considers how the industry may further green its supply chain, and thus contribute to SDG Goals 3 (Good Health and Wellbeing) and 12 (Responsible Consumption and Production), before closing on a reviewof China and India, major players who have the potential to become drivers of low-cost medical products and innovations. With its evidence-based analysis, this book will be of great interest to pharmaceutical studies, supply chain management, global health and health economics, as well as policy makers and professionals interested in the global issues facing the industry"--

This book provides a comprehensive examination of the pharmaceutical and medical device industry, including analysis of its current trade and innovation strategies.

Opening with a survey of the global pharmaceutical and medical device industry, Bhardwaj outlines the growing trade and trade interdependence among countries in the global supply chain. He adopts a trade competitiveness approach to analyse patterns of product specialisation, and examines the drug discovery process and its challenges in translating bioscientific knowledge into lifesaving products. Bhardwaj argues that further economic integration, collaborative R&D and digital technologies may help accelerate productivity and address global challenges of escalating drug costs, neglected tropical diseases (NTDs) and pandemic risks. The book also considers how the industry may further green its supply chain, and thus contribute to SDG Goals 3 (Good Health and Wellbeing) and 12 (Responsible Consumption and Production), before closing on a review of China and India, major players who have the potential to become drivers of low-cost medical products and innovations.

With its evidence-based analysis, this book will be of great interest to researchers in pharmaceutical studies, supply chain management, global health and health economics, as well as policy makers and professionals interested in the global issues facing the industry.



This book provides a comprehensive examination of the pharmaceutical and medical device industry, including analysis of its current trade and innovation strategies.

This book will be of great interest to researchers in pharmaceutical studies, supply chain management, global health and health economics.

1.Global pharmaceutical and medical device industry: Key milestones, global trading environment and key challenges
2.Evolving Product and Market Structure of the Pharmaceuticals and the Medical Device Industry
3.Trade in health products and trade interdependence
4. The innovation challenge and cross-country comparison of innovation capabilities
5. Tackling the grand challenge of productivity slowdown: New innovation strategies and the power of frontier technologies
6. Controlling neglected tropical diseases and containing the growing risks of pandemics
7. The pharmaceutical industry-environmental footprint challenge
8. Role of China and India in the emerging global supply chain: Prospects and challenges
9. Strengthening the medical sector: Concluding remarks
10. Glossary and definition of terms used
11. Appendix

Ramesh Bhardwaj is a professor of Business Economics at George Brown College, Toronto, Canada. He has written two books in Health Economics: Determinants of Mental Health: A Socioeconomic Perspective and Protecting Cancer Patients: Controlling Risk Factors, Restraining Cost of Drugs and Preventing Financial Catastrophe.